The cluster is dominated by active asset managers (Citigroup, Candriam, Aberdeen, Fiera Capital) with no passive/index fund participation, giving the signal higher conviction. Monitor the upcoming PDUFA dates (BBP-418 Nov 27, infigratinib Feb 4, encaleret May 8) as binary catalysts that could validate or challenge the institutional thesis. The absence of insider buying weakens the signal somewhat.
BBIO drugs
BBIO drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $77.93entry
- T+1 · 7d ago +0.95%α +1.32% · $78.67
- T+5 · 15h ago −0.73%α +0.96% · $77.36
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
In Q3 2026, 13 institutional investors accumulated $112.8M in net new BBIO positions, led by Citigroup (+$46M), Candriam (+$24.1M), and Aberdeen Group (new $19.9M stake), while only 5 small sellers trimmed $2.8M. The cluster follows BridgeBio's Q3 earnings report showing 193% YoY revenue growth to $353.2M and a narrowed net loss, with three upcoming PDUFA dates fully funded by $1.5B cash.
Key Financial Metrics
Institutional Positions
Net institutional flow: $112.8M
▲ Buyers (13)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Citigroup | ADD | +94% | $110.3M | $46.0M |
| Candriam S.c.a. | DOUBLED | +133.9% | $46.4M | $24.1M |
| Aberdeen Group | NEW | +0% | $19.9M | $19.9M |
| Fiera Capital | ADD | +60.6% | $33.4M | $9.9M |
| Natixis | NEW | +0% | $10.4M | $10.4M |
▼ Sellers (5)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Simplex Trading | TRIM | -42.5% | $4.1M | -$2.0M |
| Nisa Investment Advisors | TRIM | -29.3% | $497.0K | -$187.0K |
| Us Bancorp | TRIM | -60.1% | $556.0K | -$360.0K |
Key Facts
- 13 institutional buyers added $112.8M in net new BBIO positions in Q3 2026
- 5 sellers trimmed only $2.8M, making the cluster overwhelmingly one-sided buying
- Citigroup added $46.0M (+94% to $110.3M), Candriam doubled to $46.4M (+$24.1M), Aberdeen Group initiated a $19.9M position
- Q3 2026 revenue surged 193% YoY to $353.2M, net loss narrowed to $83.0M from $182.7M
- Three PDUFA dates upcoming: BBP-418 Nov 27, 2026; infigratinib Feb 4, 2027; encaleret May 8, 2027
- No open-market insider buying corroborates the institutional cluster
Financial Impact
13 institutions accumulated $112.8M in net new BBIO positions while 5 sellers trimmed $2.8M; aggregate buyer holdings reached $234.2M
Risk Factors
- 13F data is 45+ days stale; positions may have been partially or fully unwound since quarter-end
- No insider open-market buying to corroborate the institutional accumulation
- Three binary PDUFA outcomes create event risk; any rejection could reverse the thesis
- 13F filings omit short positions, so the cluster may not reflect full institutional conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BBIO-2026-Q3 |
Track record
38 reports on BBIO
10 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +26.76% at T+60 after the May 11, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $78.17 settles Dec 11
- Nov 9, 20267d ago Institutional Cluster Bullish 4/10 Viewing Entry $77.93 settles Dec 8
- Nov 6, 202610d ago Press Release Neutral 2/10 Entry $77.93 settles Dec 8
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $74.95 settles Nov 30
- Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $70.82 settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $68.12 settles Nov 19
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $63.30 to $78.67 ▲ +24.28% +27.89% vs SPY
- Oct 6, 20265w ago Press Release Bullish 7/10 Entry $66.96 to $74.03 ▲ +10.56% +13.73% vs SPY
- Oct 5, 20266w ago Press Release Neutral 2/10 Entry $66.96 to $74.03 ▲ +10.56% +13.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers